VentriPoint Diagnostics Ltd (VPT) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.146x

Based on the latest financial reports, VentriPoint Diagnostics Ltd (VPT) has a cash flow conversion efficiency ratio of 0.146x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-599.37K ≈ $-433.58K USD) by net assets (CA$-4.12 Million ≈ $-2.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of VentriPoint Diagnostics Ltd for the company's overall valuation and market capitalisation.

VentriPoint Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how VentriPoint Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

VentriPoint Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of VentriPoint Diagnostics Ltd ranked by their cash flow conversion efficiency. Explore VPT cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
BioLineRx Ltd
NASDAQ:BLRX
-0.196x
Libet S.A.
WAR:LBT
-0.036x
Great Northern Minerals Ltd
AU:GNM
-0.073x
FASING SA
WAR:FSG
0.009x
Sebata Holdings Ltd
JSE:SEB
0.031x
Reach Resources Ltd
AU:RR1
-0.032x
Xenora Minerals Ltd
AU:XRA
-0.038x
Natural Alternatives International
NASDAQ:NAII
-0.094x

Annual Cash Flow Conversion Efficiency for VentriPoint Diagnostics Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of VentriPoint Diagnostics Ltd from 2005 to 2025. View current stock price of VentriPoint Diagnostics Ltd for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$-4.12 Million
≈ $-2.98 Million
CA$-1.55 Million
≈ $-1.12 Million
0.378x -66.74%
2024-12-31 CA$-2.98 Million
≈ $-2.16 Million
CA$-3.39 Million
≈ $-2.45 Million
1.136x +105.66%
2023-12-31 CA$189.71K
≈ $137.23K
CA$-3.80 Million
≈ $-2.75 Million
-20.052x -2107.17%
2022-12-31 CA$4.55 Million
≈ $3.29 Million
CA$-4.14 Million
≈ $-2.99 Million
-0.908x -140.60%
2021-12-31 CA$8.33 Million
≈ $6.03 Million
CA$-3.15 Million
≈ $-2.28 Million
-0.378x -180.59%
2020-12-31 CA$-2.35 Million
≈ $-1.70 Million
CA$-1.10 Million
≈ $-795.98K
0.469x -51.41%
2019-12-31 CA$-2.47 Million
≈ $-1.79 Million
CA$-2.38 Million
≈ $-1.72 Million
0.964x -69.22%
2018-12-31 CA$-973.26K
≈ $-704.04K
CA$-3.05 Million
≈ $-2.21 Million
3.133x +65.95%
2017-12-31 CA$-1.63 Million
≈ $-1.18 Million
CA$-3.07 Million
≈ $-2.22 Million
1.888x +93.11%
2016-12-31 CA$-2.25 Million
≈ $-1.63 Million
CA$-2.20 Million
≈ $-1.59 Million
0.978x -83.62%
2015-12-31 CA$-269.66K
≈ $-195.07K
CA$-1.61 Million
≈ $-1.16 Million
5.967x +1033.35%
2014-12-31 CA$-2.40 Million
≈ $-1.73 Million
CA$-1.26 Million
≈ $-912.31K
0.526x -36.40%
2013-12-31 CA$-3.12 Million
≈ $-2.26 Million
CA$-2.58 Million
≈ $-1.87 Million
0.828x -49.84%
2012-12-31 CA$-2.65 Million
≈ $-1.92 Million
CA$-4.37 Million
≈ $-3.16 Million
1.650x -3.38%
2011-12-31 CA$-2.33 Million
≈ $-1.68 Million
CA$-3.98 Million
≈ $-2.88 Million
1.708x -27.65%
2010-12-31 CA$-860.17K
≈ $-622.24K
CA$-2.03 Million
≈ $-1.47 Million
2.360x +434.52%
2009-12-31 CA$-3.26 Million
≈ $-2.36 Million
CA$-1.44 Million
≈ $-1.04 Million
0.442x -80.32%
2008-12-31 CA$-1.87 Million
≈ $-1.35 Million
CA$-4.20 Million
≈ $-3.04 Million
2.244x +682.50%
2007-12-31 CA$2.50 Million
≈ $1.81 Million
CA$-965.08K
≈ $-698.12K
-0.385x -590.65%
2006-12-31 CA$670.44K
≈ $484.98K
CA$-37.40K
≈ $-27.06K
-0.056x -886.77%
2005-12-31 CA$695.36K
≈ $503.01K
CA$-3.93K
≈ $-2.84K
-0.006x --

About VentriPoint Diagnostics Ltd

V:VPT Canada Medical Devices
Market Cap
$12.22 Million
CA$16.89 Million CAD
Market Cap Rank
#26637 Global
#1086 in Canada
Share Price
CA$0.09
Change (1 day)
+0.00%
52-Week Range
CA$0.08 - CA$0.17
All Time High
CA$0.69
About

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional m… Read more